Kris Callow

Kris Callow

Company: Boehringer Ingelheim

Job title: Senior Global Medical Advisor, Retinal Health


Exploring Retinal Non-Perfusion as a Novel Target for Diabetic Retinopathy 11:30 am

Discussing the current unmet medical need in DR treatment Addressing retinal non-perfusion to target the pathophysiology of diabetic retinopathy Showcasing clinical trial design for novel compounds targeting retinal non-perfusionRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.